Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessImpact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial
Increased body mass index (BMI) has been associated with poor outcomes in women with breast cancer. We evaluated the association between BMI and pathological complete response (pCR) in the I-SPY 2 trial.
-
Article
Patient perspectives on window of opportunity clinical trials in early-stage breast cancer
Window of opportunity trials (WOT) are increasingly common in oncology research. In WOT participants receive a drug between diagnosis and anti-cancer treatment, usually for the purpose of investigating that dr...
-
Article
The WISDOM study: a new approach to screening can and should be tested